Journal article
Intraoperative Detection and Removal of Microscopic Residual Sarcoma Using Wide-Field Imaging
Cancer, Vol.118(21), pp.5320-5330
2012
DOI: 10.1002/cncr.27458
PMCID: PMC3532657
PMID: 22437667
Abstract
BACKGROUND:
The goal of limb-sparing surgery for a soft tissue sarcoma of the extremity is to remove all malignant cells while preserving limb function. After initial surgery, microscopic residual disease in the tumor bed will cause a local recurrence in approximately 33% of patients with sarcoma. To help identify these patients, the authors developed an in vivo imaging system to investigate the suitability of molecular imaging for intraoperative visualization.
METHODS:
A primary mouse model of soft tissue sarcoma and a wide field-of-view imaging device were used to investigate a series of exogenously administered, near-infrared (NIR) fluorescent probes activated by cathepsin proteases for real-time intraoperative imaging.
RESULTS:
The authors demonstrated that exogenously administered cathepsin-activated probes can be used for image-guided surgery to identify microscopic residual NIR fluorescence in the tumor beds of mice. The presence of residual NIR fluorescence was correlated with microscopic residual sarcoma and local recurrence. The removal of residual NIR fluorescence improved local control.
CONCLUSIONS:
The authors concluded that their technique has the potential to be used for intraoperative image-guided surgery to identify microscopic residual disease in patients with cancer.
Details
- Title: Subtitle
- Intraoperative Detection and Removal of Microscopic Residual Sarcoma Using Wide-Field Imaging
- Creators
- Jeffrey K MITO - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United StatesRebecca D DODD - Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United StatesJorge M FERRER - Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United StatesYongbaek KIM - Department of Clinical Pathology, College of Veterinary Medicine, Seoul National University, Seoul, Korea, Republic ofW David Lee - David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United StatesLinda G GRIFFITH - Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United StatesMoungi G BAWENDI - Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United StatesDavid G KIRSCH - Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United StatesBrian E BRIGMAN - Department of Orthopedic Surgery, Duke University Medical Center, Durham, North Carolina, United StatesChang-Lung LEE - Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, United StatesWilliam C EWARD - Department of Orthopedic Surgery, Duke University Medical Center, Durham, North Carolina, United StatesLisa F MARSHALL - Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United StatesKyle C CUNEO - Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United StatesJessica E CARTER - Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United StatesShalini RAMASUNDER - Department of Orthopedic Surgery, Duke University Medical Center, Durham, North Carolina, United States
- Resource Type
- Journal article
- Publication Details
- Cancer, Vol.118(21), pp.5320-5330
- Publisher
- Wiley-Blackwell
- DOI
- 10.1002/cncr.27458
- PMID
- 22437667
- PMCID
- PMC3532657
- ISSN
- 0008-543X
- eISSN
- 1097-0142
- Language
- English
- Date published
- 2012
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984094501202771
Metrics
17 Record Views